Special Populations Flashcards

1
Q

Geriatric PK

A
>65yo
↓total body water 53%
↓lean body mass 12% (lose muscle)
↑body fat
M 38-45%
F 36-38%
↓serum albumin 3.8g/dL
↓plasma protein = impaired protein binding
↓kidney weight 80%
↓GFR
↓hepatic blood flow 55-60% 
↓circulation time = longer onset
↑duration extended d/t metabolism/elimination changes
↓MAC 6% each decade after 40yo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Postop Delirium

A

Most common postop complication
Assess preop cognitive function
Prevention = key
Avoid benzodiazepines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Geriatric Considerations

A
Polypharmacy
Potential drug interactions w/ anesthesia
Renal impairment
↓plasma protein 
↓gastric motility
Avoid drugs w/ anticholinergic effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Muscle Relaxants

ELDERLY

A

↓skeletal muscle mass
Delayed onset
Extended DOA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anticholinergics

A
Tricyclic antidepressants
Antihistamines
Antimuscarinics
Antispasmodics
1st generation antipsychotics
H2-receptor antagonists
Skeletal muscle relaxants
Antiemetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Regional Anesthesia

ELDERLY

A

Anatomic changes in epidural & subarachnoid space
↓diameter & number myelinated fibers
↑dura permeability
↓CSF volume
Fixed dose & volume LA block spreads higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Obesity

A
Differences in tissue distribution
Hemodynamics
Blood flow to tissues
Plasma composition
Liver & kidney function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

IBW

A

Height (cm) - 100 M

Height (cm) - 105 F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lean Body Weight

A

LBW

= IBW + 30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Adjusted Body Weight

A

ABW

= IBW + 40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

IV Anesthetics

OBESITY

A

Thiopental TBW prolonged DOA & 1/2 life

Propofol LBW induction
Maintenance TBW

Midazolam TBW loading dose (higher to achieve initial therapeutic effects)
Maintenance IBW

Dexmedetomidine 0.2mcg/kg/min ↓infusion dose to prevent cardiac SE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Muscle Relaxants

OBESITY

A

Succinylcholine TBW
↑pseudocholinesterase activity

Non-depolarizing IBW
Hydrophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Narcotics

OBESITY

A

Fentanyl ?
TBW dosing overestimates

Sufentanil TBW loading dose
Maintenance LBW
↑Vd & prolonged elimination 1/2 life

Remifentanil IBW
Not effected by weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pediatric Drug Distribution

A
↓protein concentration
Blood-brain barrier
↑CBF
GFR 40mL/min at birth
↑100mL/min at 1yo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neonates/Infants

A

↓muscle mass ↑fat stores

↑blood flow to central organs (brain, heart, liver, kidneys)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Water-Soluble Drugs

PEDIATRICS

A

↑dose required

Succinylcholine

17
Q

Cell Cycle

A
  1. Cell growth
  2. DNA synthesis
  3. Mitosis
18
Q

Chemotherapy Patients ALL Experience

A

Nausea & vomiting

19
Q

Cisplatin

A

Lung, breast, ovarian, & bile duct cancers

Nephrotoxicity, peripheral neuropathy, nerve dysfunction

20
Q

Methotrexate

A

Lymphomas, breast, & bladder cancers

Myelosuppression w/ neutropenia & thrombocytopenia

21
Q

Bleomycin

A

Hodgkin’s & non-Hodgkin’s lymphoma

PULMONARY FIBROSIS

22
Q

Doxorubicin

A

Lymphomas, lung, ovarian, & thyroid cancers

Cardiotoxicity & myelosuppression

23
Q

Cetuximab

A

Colon & GI cancers

Interstitial lung disease

24
Q

Suppress NK Cell Activity

A

Volatiles
Barbiturates
Ketamine

Promote cancer cell mets

25
Q

Nitrous Oxide

A

Reduces purine & therefore DNA synthesis

Suppresses neutrophil chemotaxis, potentially facilitating cancer spread

26
Q

Opioids

A

Cellular & humoral immunosuppression

1° MORPHINE

27
Q

Propofol

A
PROTECTIVE EFFECTS
Anti-inflammatory effect
Inhibit COX-2
PGE-2 reduction
Weak β adrenoreceptor binding
Enhance antitumor immunity
NK function preservation
28
Q

Local Anesthetics

A

Reduce metastatic burden

29
Q

Cancer Surgery

IMMUNOSUPPRESSION

A
Stress
HPA stimulation
Inhaled anesthetics
Thiopental/Ketamine
Opioids & pain
Hypothermia
Blood transfusion
Inflammation
Catecholamine

PROLIFERATION
RECURRENCE
METASTASIS

30
Q

Cancer Surgery

INHIBITION

A
Regional anesthesia
Local anesthetics
Naltrexone
COX-inhibitors
β blockers